CXCR4-PET/CT for Diagnosing Giant Cell Arteritis
Vasculitis, Diagnoses Disease
About this trial
This is an interventional diagnostic trial for Vasculitis focused on measuring Vasculitis, LV-GCA, Giant cell arteritis, FDG-PET, Imaging, CXCR4
Eligibility Criteria
Inclusion Criteria: New diagnosis of GCA within 5 days of diagnosis or initiation or intensification of therapy. Evidence of inflammatory activity based on clinical parameters, elevated serologic markers of inflammation (CRP > 1.0 mg/dl), or a positive imaging finding on vasculitis MRI, CCDS, or FDG-PET/CT Ability of the patient to provide information Exclusion of contraindications for the performance of a PET/CT examination (see below) Exclusion Criteria: Contraindications for the performance of a PET CT examination Pregnancy Allergies Lack of capacity of the patient to give informed consent
Sites / Locations
- Departement of Internal Medicine II, Rheumatology/Clinical ImmunologyRecruiting
Arms of the Study
Arm 1
Experimental
CXCR4-PET experimental group
In addition to the current standard of imaging in GCA, using FDG-PET/CT, participants receive CXCR4-PET.